Allena Pharmaceuticals Correlations

ALNAQDelisted Stock  USD 0  0.00  0.00%   
The correlation of Allena Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Allena Pharmaceuticals Correlation With Market

Good diversification

The correlation between Allena Pharmaceuticals and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Allena Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Allena Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allena Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allena Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allena Pharmaceuticals to buy it.

Moving against Allena Pink Sheet

  0.49BMYMP Bristol Myers SquibbPairCorr
  0.46JPM JPMorgan Chase Sell-off TrendPairCorr
  0.4BAC Bank of America Aggressive PushPairCorr
  0.35PG Procter Gamble Sell-off TrendPairCorr
  0.32DIS Walt Disney Sell-off TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BIOAFAPTCF
TCDAQSCPS
SCPSCHNXF
BITRFCHNXF
TCDAQMRZM
TCDAQCHNXF
  
High negative correlations   
TCDAQMGTA
MGTASCPS
MRZMMGTA
TCDAQBITRF
MGTACHNXF
SCPSBITRF

Risk-Adjusted Indicators

There is a big difference between Allena Pink Sheet performing well and Allena Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Allena Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
APTCF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CMVLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CHNXF  3.06 (1.72) 0.00 (3.61) 0.00 
 0.00 
 48.28 
BITRF  3.09 (1.13) 0.00 (0.70) 0.00 
 1.34 
 62.53 
BIOAF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CDAKQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SCPS  12.77  0.26  0.01  4.68  17.13 
 35.42 
 94.02 
MGTA  2.62  0.04  0.00  0.19  3.40 
 5.88 
 16.99 
MRZM  9.89  3.01  0.07 (0.72) 9.63 
 50.00 
 128.57 
TCDAQ  8.00 (3.21) 0.00 (4.60) 0.00 
 13.33 
 76.06 

Allena Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allena Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Allena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Allena Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Allena Pharmaceuticals?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.